Oxford Nanopore Technologies PLC (ONT)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
114.80p
Buy
115.00p
1.50p (+1.32%)
Prices updated at 03 Aug 2026, 16:49 BST
| Prices minimum 15 mins delay
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Biotechnology
Chairman
Mr. Duncan Eden Tatton-Brown
CEO
Mr. Francis Van Parys
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
1,335
Head office
Edmund Halley Road
Oxford
United Kingdom
OX4 4DQ
Key personnel
Owner name | Salary |
|---|---|
Ms. Katherine Sophie Priestman Non-Executive Director, Senior Independent Director | - |
Mr. Duncan Eden Tatton-Brown Non-Executive Director, Chairman | - |
Mr. Adrian Nevil Hennah Non-Executive Director | - |
Mr. John O'Higgins Non-Executive Director | - |
Mr. Nicholas Patrick Keher Executive Director, Chief Financial Officer | - |
Mr. Francis Van Parys Executive Director, Chief Executive Officer | - |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| Baillie Gifford & Co Limited. | 19,969,731 |
| M&G Investment Management Limited | 18,875,498 |
| Edinburgh Worldwide | 12,667,767 |
| Vanguard | 10,805,540 |
| M&G UK Sustain Paris Aligned Fund | 9,407,599 |
Director dealings
Date | Action |
|---|---|
| 14 Jul 2026 | Purchase |
| 14 Jul 2026 | Transfer in |
| 14 Jul 2026 | Transfer in |
| 14 Jul 2026 | Purchase |
| 12 Jun 2026 | Transfer in |
| 12 Jun 2026 | Purchase |
| 12 Jun 2026 | Purchase |
| 12 Jun 2026 | Transfer in |
| 13 May 2026 | Purchase |
| 13 May 2026 | Transfer in |
| 13 May 2026 | Purchase |
| 13 May 2026 | Transfer in |
| 11 May 2026 | Purchase |
| 14 Apr 2026 | Exercise of Option |
| 14 Apr 2026 | Purchase |
| 14 Apr 2026 | Transfer in |
| 14 Apr 2026 | Sale |
| 14 Apr 2026 | Transfer in |
| 14 Apr 2026 | Purchase |
| 02 Apr 2026 | Purchase |
Please note that past performance is not a reliable indicator of future returns.